theMednetRegister

Allergy & Immunology   

Questions discussed in this category

Should IVIg dosing in patients with autoimmune disease (i.e., dermatomyositis) who become pregnant continue to be based on actual weight at the time of each infusion, or should it be limited to pre-pregnancy weight?
2 Answers available
Do you continue shots when a patient transfers under your care and has been receiving less than effective doses of AIT, but insist they have been effective?
2 Answers available
How often do you rely on using the C1 inhibitor functional assay versus the quantitative level alone to diagnose HAE?
2 Answers available
Is there any non-invasive validated testing for Annatto (E-160b), also known as norbixin?
1 Answer available
Can Xolair (omalizumab) be safely used in combination with biologics for patients with rheumatic disease?
Patient with chronic urticaria and rheumatoid arthritis. What would be the safest biologic option for RA?
1 Answer available
Which patient characteristics or scenarios drive you to choose tezepelumab over dupilumab for asthma?
3 Answers available
What is your surveillance protocol for patients with common variable immunodeficiency receiving chronic IVIG therapy?
Is there a target IgG level to aim for? What should hematologists be aware of in monitoring these patients?
1 Answer available
Does receiving IVIG confound the result of SPEP and/or UPEP?
2 Answers available
What is your preferred prophylactic agent in idiopathic angioedema?
1 Answer available
Are there any contraindications to starting a patient on Dupixent for prurigo nodularis if the patient is already on Xolair for asthma?
1 Answer available
Do you routinely consider FDG PET/CT imaging for workup of fever of unknown origin?
1 Answer available
What approaches can we take to initiate therapy and improve survival rates in patients with HLH?
2 Answers available
With regard to cat immunotherapy, if testing is positive for cat pelt and cat hair, do you include include 50% pelt and 50% hair if doing immunotherapy?
1 Answer available
In those patients who are initiated on omalizumab for multiple food allergies, how long should you wait before performing baked egg and baked milk challenges?
1 Answer available
Do you avoid use of inhalers with milk protein in patients with a milk allergy?
1 Answer available
When would you pursue genetic testing for severe recalcitrant atopic dermatitis?
1 Answer available
Do you find that hydroxyzine worsens cognitive symptoms in patients who are already susceptible to cognitive impairment (i.e., schizophrenia, ADHD, dementia)?
2 Answers available
Has anyone incidentally diagnosed IgA deficiency in a patient who does not present with any recurrent infections?
Is it common to have IgA deficiency in absence of any recurrent infections?
1 Answer available
Do you perform a bone marrow biopsy in all patients with grade 5 anaphylaxis to stinging insects and negative workup for HAT, MCAS, c-KIT?
1 Answer available
Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?
2 Answers available
Can Dupixent (dupliumab) be safely used in patients who are taking other biologics for rheumatic disease?
1 Answer available
How often do you find a food allergy on a skin test in an EoE patient that when avoided will result in significant resolution of EoE?
Are your results different in adults whereby a particular trigger is often found and very helpful versus in children?
1 Answer available
If you have a patient with EoE on Dupixent 300 mg weekly, and they have severe tree nut allergies, would it be safe to add Xolair for severe food allergy?
1 Answer available
Any thoughts on whether oral immunotherapy versus Xolair would provide a better chance of outgrowing a food allergy?
Will either blocking IgE better or oral food desensitization be superior in increasing chances to outgrow a food allergy?
1 Answer available
Is it necessary to prescribe a steroid taper after two weeks of high-dose prednisone (60 mg daily)?
4 Answers available
Do you switch from 0.15 mg to 0.3 mg epinephrine at 55lbs or 66lbs?
Seems like AAP and AAAI support switch to 0.3 woolen at 55lbs and FDA and Woolen package insert at 66lbs. Any thoughts on when to switch?
1 Answer available
What patients with food allergies do you screen for EoE?
Given that symptoms can overlap and food allergy symptoms can really be a manifestation of EoE in some patients, how do you decide when to screen for ...
1 Answer available
In a patient with anaphylaxis and loss of consciousness from stinging insect, suspected to be yellow jacket, the sIgE was significantly positive to all vespids, but honeybee and paper wasp were only 0.44, would you evaluate further with skin testing to wasp and decide on including wasp in treatment based on skin testing being positive or include it with just the low IgE level?
2 Answers available
Do you feel high dose Symbicort or Dulera is appropriate to use for SMART despite these doses not being studied in clinical trials?
1 Answer available
Have you been able to safely use other bisphosphonates in patients who developed an allergic reaction (angioedema) to fosamax?
1 Answer available
Is AIT safe to use with an active malignancy such as CTCL?
1 Answer available
How do you reconcile differences between SPT and serum IgE testing for aeroallergens when preparing AIT?
1 Answer available
When would you recommend prescribing an asthmatic patient budesonide/salbutamol rather than budesonide/formoterol?
2 Answers available
What functional assays do you recommend to determine if MGRPRX2 receptor activation has led to a non-IgE mediated anaphylaxis?
1 Answer available
Is there a role for use of dupilumab for hypereosinophilic GI disorders distal to the esophagus?
2 Answers available
Do you use asthma or EoE dosing if initiating dupilumab in a patient who meets criteria for treatment for both disorders?
1 Answer available
Do you utilize AIT for atopic dermatitis if there is no AR present?
4 Answers available
What parasites do you screen for in your workup of HES?
1 Answer available
How would you treat autologous GVHD after a thymic transplant but with no thymopoeisis?
1 Answer available
Is omalizumab an option for a patient needing a specific antibiotic with an IgE-mediated reaction who continues to have reactions during a desensitization?
1 Answer available
How do you reassure families that no allergy testing is needed for urticaria?
2 Answers available
Do you utilize urinary leukotrienes as a marker for initiation of montelukast?
1 Answer available
What VIT would you recommend in a patient who had grade 5 anaphylaxis to a stinging insect but negative IDT and serum IgE?
2 Answers available
How often do you monitor the eosinophil count after initiating anti-IL5 therapy for HAE?
1 Answer available
How do you approach performing a food challenge in a patient with CSU who is dependent on their H1 blockers?
1 Answer available
Is separating dust mite and molds still necessary in light of increased addition of glycerol to IT mixtures?
1 Answer available
Do you perform genetic testing when patients have persistent hypogammaglobulinemia after rituximab therapy?
2 Answers available
How do you approach treating patients who develop psoriasis while on Dupixent?
Do you start/trial them on another biologic or just rely on topical therapies?
1 Answer available
Do you continue to check tryptase levels in your patients with idiopathic anaphylaxis despite normal levels >5 on repeated checks?
1 Answer available
What are the implications of checking post-vaccine titers after administration of Prevnar 20 compared to PPSV23?
1 Answer available
In those patients who are initiated on omalizumab for multiple food allergies, once baked egg and baked milk are introduced into the diet, how long should you wait until a prepared egg and whole milk challenge is conducted?
1 Answer available
Do you counsel a mother to avoid certain food in her diet if she is still breast feeding and her child has confirmed IgE mediated food allergies?
1 Answer available
What is your experience managing patients with chronic spontaneous urticaria occurring only at night?
Female in her early 40s with chronic spontaneous urticaria occurring consistently only at night for the past 4 years. Lesions develop only at night wh...
1 Answer available
Is there a role for phenotyping patients with CSU outside of a research setting by ordering IgG-anti-TPO, IgG-anti-FceRI , total IgE, total IgA etc.?
1 Answer available
How does omalizumab play a role in the armamentarium of atopic dermatitis?
1 Answer available
Do you recommend IM Kenalog injection for refractory CRSwNP in a patient already on maximal therapy?
1 Answer available
Do you look for local IgE production in the nares with negative SPT and IgE testing if the clinical history suggests AR and the patient desires AIT?
1 Answer available
Are you requiring markers other than LTE4 to be elevated to diagnose MCAS?
There has been new data to suggest LTE4 is not the best urinary marker of mast cell activation, so are you requiring other markers to be elevated to d...
1 Answer available
Is methacholine challenge on its way out?
1 Answer available
Is there a role for biologics to improve lung function in patients who have severe asthma with daily symptoms and reduced lung function but do not experience frequent exacerbations?
2 Answers available
Are systemic effects from corticosteroid use greater with budesonide rinses compared to nasal sprays?
1 Answer available
Would you favor treating HES manifesting with EoE with dupilumab or anti-IL5 therapy?
1 Answer available
Is there a role for nitazoxanide for treatment of norovirus gastroenteritis in immunocompromised patients?
1 Answer available
Is there a role for anti-IL5 therapy in the treatment of EoE?
1 Answer available
What are the implications of immunosuppressive therapy in a chronic asymptomatic T cell lymphopenic adult undergoing lung transplant evaluation?
1 Answer available
Do you recommend food elimination diets for GI eosinophilic disorder not affecting the esophagus?
1 Answer available
Do you give additional pneumococcal vaccines after a dose of PCV20 in patients with asplenia?
1 Answer available
Do you favor 24 hour urinary metabolites over random urine collection when screening for MCAS?
1 Answer available
What methods have you found successful in getting young children to use nasal sprays?
1 Answer available
Which types of patients do you treat with prolonged antibiotics before obtaining a CT sinus?
2 Answers available
In those patients who are initiated on omalizumab for multiple food allergies, once baked egg and baked milk are introduced into the diet, do you rely upon skin prick testing and/or ImmunoCAP testing in order to make the decision to introduce prepared egg or whole milk into the diet?
2 Answers available
Is there a role for omalizumab in a patient who is on VIT but still experiences anaphylaxis to stinging insects?
1 Answer available
How exhaustive (especially considering cost) should an immunological workup be for patients with extensive, recurrent, or deep seated Staph aureus infections without obvious immunocompromise (e.g. cancer, diabetes, steroids) or recurrent breaks in skin integrity?
1 Answer available
How do you recommend spacing dosing between immunoglobulin replacement and eculizmab administration?
1 Answer available
How do you approach work up for underlying rheumatologic disease in patients referred for chronic urticaria?
2 Answers available
Do you diagnose MCAS if a patient is concurrently on drugs known to cause non-specific mast cell degranulation?
1 Answer available
What treatments do you consider for cholinergic urticaria refractory to high dose H1 blockers and omalizumab?
1 Answer available
How do you factor smoking history into biologic selection for asthma since the clinical trials generally excluded these patients?
1 Answer available
How do you manage introduction of other seeds when the patient has never been exposed and has a sesame allergy?
1 Answer available
How do you utilize cytokine panels in your clinical practice?
Is there utility when classic inflammatory markers (ESR,CRP) or disease specific markers (C3, C4, dsDNA) do not correlate with patients disease activi...
1 Answer available
How do you decide when to obtain genetic testing for suspected autoinflammatory conditions in adults?
2 Answers available
What factors do you consider prior to offering a trial of ICS/LABA therapy versus a methacholine challenge test in patients with suspected asthma but normal pulmonary function testing?
1 Answer available
For which patients could you consider direct oral amoxicillin challenge as opposed to skin testing for penicillin allergy de-labeling?
1 Answer available
How do you approach patients that develop atopic dermatitis while on biologics for psoriasis?
I have an elderly patient with a history of biopsy-proven psoriasis on IL-17 biologic therapy. She has developed an intense itch without a primary ras...
1 Answer available
How do you manage atopic dermatitis in pediatric patients who has failed dupilumab?
(preschool-aged patients)
1 Answer available
Do you diagnose obstruction by the criteria of FEV1/FVC < 70% or < LLN?
5 Answers available
How would you work up a patient with cutaneous mastocytosis?
Is a BM biopsy a must when there is skin involvement? If tryptase level is mildly elevated but less than 20 would you recommend a BM biopsy?
1 Answer available
What is your approach to working up diarrhea in an immunocompromised patient?
1 Answer available
Do you utilize post-vaccination IgG titers to detect common variable immunodeficiency in patients who are about to start or are actively on B cell depleting therapy?
2 Answers available
What is your approach to inhaler therapy in a patient with asthma who cannot be on an inhaled corticosteroid due to ocular disease?
1 Answer available
Do you have to remove gold dental crowns if patch testing reveals a gold allergy?
1 Answer available
How would you treat a woman with iron deficiency anemia, unresponsive to iron sulfate, and with allergic reaction to iron sucrose?
Anemia is secondary to menorrhagia. No gynecologic interventions were possible.
1 Answer available
Do you prescribe fluocinolone in peanut oil in patients with peanut allergies?
3 Answers available
How do you perform patch testing in patients who are allergic to adhesives?
1 Answer available
How do you manage recurrent urticarial lesions in a patient with underlying connective tissue disease that is otherwise well-controlled?
3 Answers available
Would you avoid combining JAK inhibitors with IVIG given the risk of thromboembolism?
4 Answers available
What is your threshold to start triple therapy in mild to moderate asthma/COPD overlap with minimal functional limitation?
1 Answer available
Does Dupixent interfere with patch testing?
https://www.jaad.org/action/showPdf?pii=S0190-9622%2824%2903329-2
1 Answer available
What are best practices in management of severe acute infusion reaction from infliximab?
Patient became acutely flushed, developed severe and prolonged hypotension with brief loss of consciousness, dizziness, nausea, dry heaves and headach...
1 Answer available
Is there a role for biologics to help patients with ABPA who are steroid responsive and have removed their allergen insult, but continue to have an elevated serum IgE and incomplete resolution of symptoms return to their baseline functional status?
1 Answer available
Should testing for genetic causes of HLH be performed in all patients with MAS or secondary HLH regardless of the patient's age?
2 Answers available
Is there a role for the use of biologics as steroid sparing agents in treating patients with ABPA who are intolerant to prednisone?
1 Answer available
How do you counsel parents of children with atopic dermatitis about preventing recurrent Staph infections?
Are dilute bleach baths enough? Should they use any topical therapies? Is there a need for Staph decolonization with something like mupirocin?
1 Answer available
Do you use continuous or intermittent bronchodilator therapy in severe airway obstruction?
1 Answer available
What is your second line therapy for patients with EGPA with mainly pulmonary and sinonasal features who did not respond to mepolizumab 300 mg/month and still require high doses of steroid?
2 Answers available
What is the optimal timing for Zoster vaccine administration for a patient who recently recovered from herpes zoster infection and is now planning to start B-cell depletion therapy?
1 Answer available
Is the efficacy and dose same for subcutaneous vs intravenous IVIGs being used for dermatomyositis?
1 Answer available
What are the best labs to trend improvement in HLH?
1 Answer available
What is your approach to checking IgG levels post vaccination to detect common variable immunodeficiency in patients with systemic lupus?
If a deficiency is present, do you consider IVIG to treat non-infectious symptoms such as skin rash, arthritis or hematological abnormalities? 
1 Answer available
When do you refer pediatric patients with eczema to an allergist?
Are there cases where food or environmental allergies significantly worsen eczema in children?
1 Answer available
Do you recommend allopurinol desensitization in gout patients who develop a rash on allopurinol therapy?
2 Answers available
Is there any PFT criteria that you use in guiding decision making to offer transbronchial lung cryobiopsy to patients with interstitial lung disease?
1 Answer available
Is there a role for biologic therapies in asthma-COPD overlap syndrome with evidence of type 2 inflammation?
2 Answers available
With the approval of oral JAK inhibitors such as Upadacitinib for atopic dermatitis, how are you considering its safety profile in comparison to traditional immunosuppressants such as prednisone, methotrexate, azathioprine, and mycophenolate?
Especially in the setting of these being more narrow acting than tofacitinib, should we consider them safer than our old drugs?
2 Answers available
What is your approach to treating patients with dupilumab induced facial redness?
2 Answers available
Would you have any hesitation to use belimumab in a patient with IgA deficiency?
1 Answer available
Do you avoid dupilumab (IL-4 inhibition) for severe asthma in patients already taking a biologic agent for RA?
1 Answer available
Should we recommend the COVID-19 booster vaccine to patients who had a DVT or any other complications such as hemolytic anemia or thrombocytopenia from prior vaccine doses?
2 Answers available
How do you treat post-IVIG headache that is not responsive to Tylenol or NSAIDs?
Specifically, how do you treat the delayed headache, not the headache that develops during the infusion where pre-hydration and slowing down the rate ...
4 Answers available
Is there a role for antibody testing to confirm vaccine response for patients on rituximab after COVID-19 vaccination?
1 Answer available
Do you recommend COVID vaccination in patients with antiphospholipid antibody positivity or other prothrombotic states not on anti-coagulation?
1 Answer available
How are you timing the third dose of the COVID-19 mRNA vaccine in patients on rituximab?
1 Answer available
In which patients with autoimmune or inflammatory conditions are you recommending a 3rd dose of the mRNA COVID vaccine?
2 Answers available
How do you approach an isolated T-cell gene arrangement found in the setting of persistent hypereosinophilia?
If all work-up including peripheral flow, bone marrow biopsy, PET-CT returns negative, what additional management (if any) would be recommended?
1 Answer available
Are there any special considerations when evaluating patients with non-malignant hematologic or immunodeficiency disorders for allogeneic transplant?
Are there major differences in standard conditioning and/or GVHD prophylaxis regimens utilized? Does the non-relapse mortality different significantl...
3 Answers available
What is your preferred regimen for remission induction and maintenance in EGPA with cardiac involvement?
1 Answer available
How would you advise patients with known stable autoimmune thrombocytopenia regarding the Ad26.COV2.S (Johnson & Johnson/Janssen) vaccine?
1 Answer available
How do you advise patients who had autoimmune diseases "triggered" by COVID infections on getting COVID vaccination?
E.g., inflammatory polyarthritis or inflammatory myopathy with onset within 2 weeks of documented COVID infection
1 Answer available
How would you recommend dosing the MMR or other live vaccines for patients with rheumatoid arthritis on immunosuppressive medications such as anti-TNF alpha therapy?
For example, healthcare workers who require these vaccines for employment
1 Answer available
Is it okay to use medications associated with drug-induced lupus in patients with SLE?
1 Answer available
Which EGPA patients are most likely to benefit from treatment with anti-IL-5 agents such as mepolizumab?
1 Answer available
How does a history of splenectomy alter how you counsel patients on the infection risk of TNF inhibitors or other biologics?
1 Answer available
For which rituximab infusion reaction symptoms do you consider it safe to re-challenge in the office with adjusted rates and pre-medications?
1 Answer available
Do you recommend shingles vaccine to all immunosuppressed patients under the age of 50 y.o.?
1 Answer available
How do you handle hypogammaglobulinemia detected in patients prior to maintenance rituximab infusion?
2 Answers available
Which ANCA vasculitis patients are better candidates for cyclophosphamide rather than rituximab?
2 Answers available
How does your treatment algorithm differ for drug-induced ANCA vasculitis compared to non drug-induced ANCA vasculitis in cases with severe/organ-threatening manifestations?
1 Answer available
Do you prescribe silvadene cream for patients with a sulfa allergy?
2 Answers available


Papers discussed in this category

The New England journal of medicine, 2010-07-15
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.
Medicine (Baltimore),
The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort.
The New England journal of medicine, 2010-07-15
Rituximab versus cyclophosphamide for ANCA-associated vasculitis.
JAMA network open, 2018-11-02
Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia.
The journal of allergy and clinical immunology. In practice, 2017
Reactions to Rituximab in an Outpatient Infusion Center: A 5-Year Review.
N Engl J Med,
Clinical practice. Care of the asplenic patient.
Mediterr J Rheumatol, 2020 Jun 11
Infections in Patients with Rheumatoid Arthritis in the Era of Targeted Synthetic Therapies.
The New England journal of medicine, 2017-05-18
Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis.
Ann Rheum Dis, 2019 Aug 14
2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases.
Lancet Rheumatol, 2021 Apr 06
Incident systemic rheumatic disease following COVID-19.
N Engl J Med, 2020 Nov 20
Covid-19-Associated Myopathy Caused by Type I Interferonopathy.
Blood,
Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance.
European journal of haematology, 2017-04
IgG4-related disease and lymphocyte-variant hypereosinophilic syndrome: A comparative case series.
J Allergy Clin Immunol Pract, 2021 Feb 03
CD3CD4 Lymphocytic Variant Hypereosinophilic Syndrome: Diagnostic Tools Revisited.
Eur J Haematol, 2020 May 18
Causes of hypereosinophilia in 100 consecutive patients.
Br J Haematol, 2019 Nov 13
Pegylated interferon alpha 2a is an effective and well-tolerated treatment option for lymphocyte-variant hypereosinophilic syndrome.
Br J Haematol, 2021 Jun 08
Treatment of lymphocyte-variant hypereosinophilic syndrome (L-HES): what to consider after confirming the elusive diagnosis.
Arthritis Rheumatol, 2021 May 24
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 1.
Semin Hematol,
Epidemiology and risk factors for venous thrombosis.
Thromb Res, 2021 Jun 25
Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot study.
The New England journal of medicine, 2018-03-29
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout.
Lancet, 2020 Nov 09
Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial.
Lupus, 2013-02
Safety profile of belimumab: pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosus.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000-04
Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America.
Chest, 2018 Jan 11
A Randomized Trial of Itraconazole vs Prednisolone in Acute-Stage Allergic Bronchopulmonary Aspergillosis Complicating Asthma.
J Allergy Clin Immunol Pract, 2021 Mar 06
Real-World Effectiveness of Anti-IL-5/5R Therapy in Severe Atopic Eosinophilic Asthma with Fungal Sensitization.
Chest, 2020 Aug 31
Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma.
J Allergy Clin Immunol Pract, 2020 Jun 16
Omalizumab Is an Effective Intervention in Severe Asthma with Fungal Sensitization.
Cureus, 2020 Aug 12
Mepolizumab as Possible Treatment for Allergic Bronchopulmonary Aspergillosis: A Review of Eight Cases.
J Allergy Clin Immunol Pract, 2015 Jan 29
Clinical efficacy and immunologic effects of omalizumab in allergic bronchopulmonary aspergillosis.
Eur J Dermatol,
Telangiectasia macularis eruptiva perstans: a neglected type of mastocytosis with exclusively cutaneous involvement? A case series.
Pediatric blood & cancer, 2011-01
Rate of decline of ferritin in patients with hemophagocytic lymphohistiocytosis as a prognostic variable for mortality.
Semin Arthritis Rheum, 2007 Feb
Common variable immunodeficiency in systemic lupus erythematosus.
J Clin Rheumatol, 2021 Dec 01
Intravenous Immunoglobulin for Inflammatory Myositis: Experience in a Tertiary Medical Center.
Am J Med, 1984 Mar 30
Immunoglobulin G (IgG) subclasses and human disease.
Lupus, 2007
Selective IgA deficiency in children and adults with systemic lupus erythematosus.
Autoimmun Rev, 2022 Aug 24
Efficacy and safety of intravenous immunoglobulin in patients with lupus nephritis: A systematic review of the literature.
The New England journal of medicine, 1993-12-30
A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis.
N Engl J Med, 2022 Oct 06
Trial of Intravenous Immune Globulin in Dermatomyositis.
Lancet, 1987 May 09
High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease.
Int J Stroke, 2018 May 22
Multisociety Consensus Quality Improvement Revised Consensus Statement for Endovascular Therapy of Acute Ischemic Stroke.
Curr Rheumatol Rev, 2018
Subcutaneous IgG in the Myositis Spectrum Disorders.
Clin Rheumatol, 2014 Jan 07
Open-label study on treatment with 20 % subcutaneous IgG administration in polymyositis and dermatomyositis.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2023 Feb 11
Eczematized psoriasis - a frequent but often neglected variant of plaque psoriasis.
The American journal of gastroenterology, 2003 Jun
The incidence and management of infusion reactions to infliximab: a large center experience.
The Journal of rheumatology, 2015 Jun 15
Incidence and Management of Infusion Reactions to Infliximab in a Prospective Real-world Community Registry.
The Journal of allergy and clinical immunology, 2012 Feb 14
Chronic urticaria and autoimmunity: associations found in a large population study.
Journal of the American Academy of Dermatology, 2003-04
Fluocinolone acetonide 0.01% in peanut oil: therapy for childhood atopic dermatitis, even in patients who are peanut sensitive.
Arthritis & rheumatology (Hoboken, N.J.), 2023 Jul 24
The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS).
The New England journal of medicine, 2023 May 04
Reappraisal of Idiopathic CD4 Lymphocytopenia at 30 Years.
The American journal of case reports, 2019 Jul 06
Safety of an Abbreviated Transition Period When Switching From Intravenous Immunoglobulin to Eculizumab in Patients with Treatment-Refractory Myasthenia Gravis: A Case Series.
The Journal of allergy and clinical immunology, 2021 Apr 20
Rituximab-induced hypogammaglobulinemia and infection risk in pediatric patients.
European journal of immunology, 2022 Aug 10
Secondary rituximab-associated versus primary immunodeficiencies: The enigmatic border.
Allergy, 2021 Oct 20
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria.
Allergy, asthma & immunology research, 2020 Sep
Omalizumab Treatment in Patients With Cholinergic Urticaria: A Real-World Retrospective Study in Korea.
The journal of allergy and clinical immunology. In practice, 2018 Jul-Aug
How to Approach Chronic Inducible Urticaria.
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2009 Nov 23
Recommendations for performing and evaluating the results of the minor test according to a sweating intensity visual scale.
American journal of clinical dermatology, 2022 Sep 15
Cholinergic Urticaria: Subtype Classification and Clinical Approach.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2008-03
Allergy diagnostic testing: an updated practice parameter.
The Journal of allergy and clinical immunology, 2001 Jul
Corticosteroids in the treatment of pediatric allergic rhinitis.
The Journal of allergy and clinical immunology, 2020 Jul 22
Rhinitis 2020: A practice parameter update.
The Journal of allergy and clinical immunology, 2004 Mar
Contamination of dry powder inhalers for asthma with milk proteins containing lactose.
Journal of clinical medicine, 2022 Dec 10
Lactose-Containing Dry-Powder Inhalers for Patients with Cow's Milk Protein Allergy-The Conundrum; A National Survey of Pediatric Pulmonologists and Allergologists.
The Journal of allergy and clinical immunology, 2023 Jul 18
Prospective study of an amino acid-based elemental diet in an eosinophilic gastritis and gastroenteritis nutrition trial.
The Journal of allergy and clinical immunology, 2012-02
Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial.
Gut, 2023 Jul 09
Mepolizumab for treatment of adolescents and adults with eosinophilic oesophagitis: a multicentre, randomised, double-blind, placebo-controlled clinical trial.
The New England journal of medicine, 2024 Jun 27
Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis.
The Journal of allergy and clinical immunology, 2010-09
Successful use of omalizumab for prevention of fire ant anaphylaxis.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2010 Jun
Omalizumab monotherapy for bee sting and unprovoked "anaphylaxis" in a patient with systemic mastocytosis and undetectable specific IgE.
The Journal of allergy and clinical immunology, 2022 Sep 30
Allergen immunotherapy for atopic dermatitis: Systematic review and meta-analysis of benefits and harms.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2023 Dec 18
Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations.
The journal of allergy and clinical immunology. In practice, 2022 Mar 26
Nontryptase Urinary and Hematologic Biomarkers of Mast Cell Expansion and Mast Cell Activation: Status 2022.
The journal of allergy and clinical immunology. In practice, 2022 Mar 25
Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User's Guide for Daily Clinical Practice.
Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2019 Feb 04
Omalizumab for atopic dermatitis: evidence for and against its use.
The Journal of allergy and clinical immunology, 2016 Jul 14
Efficacy of omalizumab in patients with atopic dermatitis: A systematic review and meta-analysis.
JAMA pediatrics, 2020 Jan 01
Treatment Effect of Omalizumab on Severe Pediatric Atopic Dermatitis: The ADAPT Randomized Clinical Trial.
The New England journal of medicine, 2024 Feb 25
Omalizumab for the Treatment of Multiple Food Allergies.
The journal of allergy and clinical immunology. In practice, 2019 Feb 20
Impact of Omalizumab on Food Allergy in Patients Treated for Asthma: A Real-Life Study.
The journal of allergy and clinical immunology. In practice, 2019 Feb 26
Skin Testing and Specific-IgE Following IVIG or Omalizumab.
International archives of allergy and immunology, 2016 Jan 21
Influence of Omalizumab on Allergen-Specific IgE in Patients with Adult Asthma.
The Journal of infection, 2011-11
Norovirus gastroenteritis successfully treated with nitazoxanide.
Alimentary pharmacology & therapeutics, 2006 Nov 15
Nitazoxanide in the treatment of viral gastroenteritis: a randomized double-blind placebo-controlled clinical trial.
Journal of tropical medicine, 2017 Feb 26
Nitazoxanide in Acute Rotavirus Diarrhea: A Randomized Control Trial from a Developing Country.
Lupus, 2014 Jul 30
Serious infections in systemic lupus erythematosus with a focus on pneumococcal infections.
MMWR. Morbidity and mortality weekly report, 2024 Sep 12
Use of 21-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024.
Journal of the Endocrine Society, 2022 Dec 02
Perioperative Evaluation and Management of Patients on Glucocorticoids.
Diagnostics (Basel, Switzerland), 2021 Apr 20
Glucocorticoid Withdrawal-An Overview on When and How to Diagnose Adrenal Insufficiency in Clinical Practice.
International journal of molecular sciences, 2023 Jul 11
Biomarkers for Monitoring Treatment Response of Omalizumab in Patients with Chronic Urticaria.
The American journal of medicine, 2024 Mar 16
The Contribution of 18F FDG PET-CT for the Investigation of Fever of Unknown Origin and Inflammation of Unknown Origin.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 1995-02
Chronic sulfasalazine therapy in the treatment of delayed pressure urticaria and angioedema.
The journal of allergy and clinical immunology. In practice, 2021 Mar
Biologics for the Use in Chronic Spontaneous Urticaria: When and Which.
The journal of allergy and clinical immunology. In practice, 2021 Apr 20
The Diagnostic Workup in Chronic Spontaneous Urticaria-What to Test and Why.
The journal of allergy and clinical immunology. In practice, 2020 Mar 13
Delayed Pressure Urticaria: A Systematic Review of Treatment Options.
The Journal of allergy and clinical immunology, 2012-09
Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology.
Immunology and allergy clinics of North America, 2020 Jun 09
Diagnosis and management of Specific Antibody Deficiency.
Journal of clinical immunology, 2019 Nov 08
Defining Polysaccharide Antibody Deficiency: Measurement of Anti-Pneumococcal Antibodies and Anti-Salmonella typhi Antibodies in a Cohort of Patients with Recurrent Infections.
Frontiers in immunology, 2021 Sep 30
Diagnostic Vaccination in Clinical Practice.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2021 Feb 24
Provider recommendations and maternal practices when providing breast milk to children with immunoglobulin E-mediated food allergy.
The Journal of allergy and clinical immunology, 2008 Sep
Allergen immunotherapy: what can and cannot be mixed?
Clinical and translational allergy, 2020 Jan 29
Modified protocol of omalizumab treatment to prevent carboplatin-induced drug hypersensitivity reactions: a case study.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2023 Dec 18
Anaphylaxis: A 2023 practice parameter update.
The Journal of allergy and clinical immunology, 2024 Aug 05
Advances and ongoing challenges in eosinophilic gastrointestinal disorders presented at the CEGIR/TIGERs Symposium at the 2024 American Academy of Allergy, Asthma & Immunology meeting.
Immunology and allergy clinics of North America, 2024 Feb 16
Dietary Management of Eosinophilic Esophagitis.
The Journal of allergy and clinical immunology, 2011-01
Allergen immunotherapy: a practice parameter third update.
The journal of allergy and clinical immunology. In practice, 2023 Jun 28
The Art of Dosing for Subcutaneous Immunotherapy in North America.
Medicine, 2021 Jan 08
Prospective, double-blind, randomized, placebo-controlled phase III study evaluating efficacy and safety of octagam 10% in patients with dermatomyositis ("ProDERM Study").
Curr Rheumatol Rep, 2023 Aug
Intravenous Immunoglobulin in Idiopathic Inflammatory Myopathies: a Practical Guide for Clinical Use.
NeoReviews, 2021 Jan
Update on the Use of Intravenous Immunoglobulin in Pregnancy.
Journal of clinical pharmacology, 2023 Jun
Physiologic Changes During Pregnancy and Impact on Small-Molecule Drugs, Biologic (Monoclonal Antibody) Disposition, and Response.
The Journal of dermatological treatment, 2018 Sep 25
Combined treatment with omalizumab and etanercept in a patient with chronic spontaneous urticaria and rheumatoid arthritis.

Related Topics

Copyright © 2024 theMednet
All Rights Reserved.